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Concanavalin A - i n d m  lymphocyte proliferation was studied in 25 
patients with alcoholic hepatitis or compensated alcoholic cirrhosis. 
Nine alcoholics wilhoul evidence of liver disease were also evalu- 
ated. A nonlinear correlation equation, which was natural logatfthmic, 
was applied to indhrldud dose-mponse proliferation curves and 
permitted comparhm between patient groups and controls. The 
proliferative maponso In dl patienl groups was significantly lower 
when compamd to healthy contrds and was independent of the 
presence or absence of liver disease. This suggests that some 
changes in immune function obsenred in alcoholics may be linked to 
the direct effect. of alcohol on the immune system rather than to the 
associated llver d b w .  
YMPHOPROLIFERATIVE RESPONSES to nonspe- L cific mitogen stimulation have been employed to 
assess immunological function in healthy individuals as 
well as in patients with a variety of diseases. Mitogen- 
induced proliferation and, modulation of such reactivity, 
is subject to influence by multiple factors which would 
include the stimulating agent, the source and composition 
of the lymphocytes, culture conditions, and the immune 
status of the  subject.'^' 
Comparisons of lymphoproliferative responses between 
groups of disease-related patients and healthy subjects is 
dificult since the mitogen dose-response relationship is 
nonlinear. Most studies have used Student's t test to 
compare differences between groups at each mitogen dos- 
age, however considerable individual variation exists in 
the magnitude of the response. In other approaches the 
optimal response of peripheral blood mononuclear (PBM) 
cells to increasing concentrations of a single mitogen is 
related to the response of the same PBM to a second 
mit~gen.~ Most frequently a single dose of mitogen is used 
which is derived from the peak proliferative response 
exhibited by control PBM. 
Conflicting results have been reported on lymphocyte 
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transformation assays in patients with alcoholic liver dis- 
ease (ALD). Decreased proliferative responses to the mi- 
togens phytohemagglutinin (PHA) and concanavalin (Con 
A) have been described in patients with alcoholic hepatitis 
(AH)4-7 and in patients with compensated alcoholic cir- 
rhosis (CAC) or fatty infiltration.49798 However, normal 
proliferative responses have also been reported in patients 
with AH,9 CAC or fatty infil trati~n.~.~~" In a similar 
manner both decreased mitogen-induced proliferative 
responses' ' and normal responses4. 5 3 9  have been described 
in alcoholics without liver disease. 
Recently a natural logarithmic relationship was de- 
scribed between mitogen stimulation and human lympho- 
cyte response in a dose-response proliferation assay.'' 
Application of a nonlinear correlation equation to individ- 
ual proliferation curves may permit quantitative compar- 
isons between groups of patients and controls. 
We measured the proliferative response to increasing 
doses of Con A by PBM isolated from alcoholic patients 
and from healthy volunteers. Comparisons of the re- 
sponses were accomplished using a natural logarithmic 
relationship equation. 
PATIENTS AND METHODS 
Study Groups 
Twenty-five patients with ALD were studied. Fourteen patients (nine 
males and five females) were considered to have AH on the basis of 
clinical and laboratory findings to include the following criteria after at 
least 5 days in the hospital: Recent alcohol consumption in excess of 1 
pint of whiskey per day or its alcohol equivalent; hepatomegaly; a total 
serum bilirubin 2 4 mg%; and abnormalities in at least two of the 
following parameters: ( a )  &rum glutamic oxdoacetic transaminase 
(SCOT) more than 80 IU/ml (normal c 40 IU), ( b )  serum albumin 5 3 
g%, or ( c )  prothrombin time 2 2 sec in excess of the control value. 
Coagulation deficiencies and/or the presence of ascites precluded per- 
cutaneous liver biopsy in all but four of these patients. In all cases where 
biopsy was accomplished, the clinical diagnosis of AH was confirmed by 
the presence of alcoholic hyalin, liver cell necrosis, and polymorphonu- 
clear neutrophil infitrate. Two of the biopsies revealed concomitant 
micronodular cirrhosis (Table 1). 
Eleven alcoholic patients (eight males and three females) were diag- 
nosed as having CAC following liver biopsy in which features of a 
superimposed hepatitis were not identified (Table 1). 
Nine AWLD (all males) were studied to determine the influence of 
recent chronic alcohol ingestion on PBM function. These patients were 
selected from the inpatient alcohol rehabilitation service of the Ann 
Arbor Veterans Administration Medical Center. All patients were ex- 
amined at least 7 days following admission and had ingested a minimum 
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Table 1. Liver Functii Profile of Patient Groups 
Serum Prothrombin 
Total serum bilirubin alkaline phosphatase SGOT Serum albumin time prolongation 
Group Age (Yrs) (mg/l00 m9 (Iu) (Iu) (g/lOO ml) (S) 
AH’ 39 f 3 14.8 -c 2.8 244 * 23 154 f 22 2.4 k 0.1 4.3 f 0.7 
CAC 54 2 14 1.3 * 0.3 171 f 24 52 f 17 3.7 f 0.2 0.8 f 0.3 
AWLD 44 f 3 0.4 f 0.1 69 f 8 42 f 13 4.6 f 0.1 NDt 
Values, means f SEM. 
AH, alcoholic hepatitis; CAC. compensated alcoholic cirrhosis; AWLD, alooholii without liver disease. 
t ND, not done. 
of 1 pint of whiskey or its equivalent per day prior to admission. 
Laboratory studies showed normal or mild elevations in serum SGOT, 
total bilirubin, and alkaline phosphatase values. None of the patients had 
hepatomegaly or clinical findings to suggest acute or chronic liver disease. 
Liver biopsies were not obtained. Control subjects consisted of 5 1 healthy 
volunteers (39 males, 12 females; 32 * 2 yr) not known to abuse alcohol 
or to be using medication. This study was approved by the Ann Arbor 
Veterans Administration Medical Center Human Studies Committee. 
Isolation of PBM 
Freshly heparinked peripheral blood was drawn from patients and 
controls and PBM isolated using Ficoll-Hypaque gradient as previously 
described (13). Cells were resuspended in RPMI 1640 (GIBCO, Grand 
Island, NY) enriched with vitamins, 2 mM glutamine, penicillin (100 
units/ml), streptomycin (100 pg/ml), and 10% heat-inactivated fetal calf 
serum (FCS, Hyclone, Sterile System, Inc., Logan, VT). 
Prolifeation Assay 
PBM, 0.15 ml (1 X lo5 cells), were added to 0.05 ml of increasing 
concentrations of Con A (Pharmacia Fine Chemicals, Piscataway, NJ) 
in wells of a round-bottom microtiter culture plate (Falcon Plastics, 
Oxnard, CA). The final concentrations of Con A in the wells were 0, 1, 
5 ,  10, 20, and 40 pglml. All experiments were performed in triplicate. 
The plates were incubated at 37°C for 72 h in a humidified 5% CO, and 
air atmosphere. Tritiated thymidine, 1 pCi (New England Nuclear, 
Waltham, MA), was added to each well 4 h prior to harvesting with an 
automatic multiple sample harvester (Otto Hiller Co., Madison, WI). 
The incorporation of [’Hlthymidine was measured in a Beckman liquid 
scintillation system. PBM from control subjects were always included in 
assays in which alcoholic patients were studied. 
Statistical Analysis 
The proliferation ratio (PR) of each condition for each subject was 
determined using the equation, PR = B + Kp In [XJ, where In = log, 
natural logarithm, X = Con A concentration, B = basal PR, and K, = 
proliferation coefficient. 
A personal computer (PC) program using BASIC language as previ- 
ously described” enabled complete data calculations to obtain Kp, B, and 
r correlation coefficient values from (kc input of each Con A dose and 
the response in cpm. Comparisons of discrete variables between patient 
groups and controls were by Student’s t test. 
RESULTS 
To assess for possible age-related differences in the 
Proliferative responses of the control group,l4 the healthy 
volunteers were divided into two age groups: 20-40 years 
and 41-60 years. As shown in Table 2, there were no 
significant differences between the two age groups or 
between the two groups and the total control group in 
either the cpm at each Con A concentration or in the Kp 
values. 
Signscant differences in cpm were noted at several Con 
A Concentrations when comparing the AH and CAC 
responses to those of the controls. A consistent decrease 
in proliferative response was seen in the AWLD at all 
mitogenic concentrations of Con A (Table 3). Although 
the three patient groups (AH, CAC, and AWLD) had 
significantly lower Kp values than the control group, all 
study groups displayed highly significant natural logarith- 
mic correlations when comparing proliferation ratios and 
each concentration of Con A in the proliferation assay 
(Table 4). 
DISCUSSION 
The Kp values observed for the AH, CAC, and AWLD 
groups confirm that there is a decrease in lymphocyte 
proliferative responses to mitogen stimulation in these 
patients. Our results, in part, also provide an explanation 
for the conflicting observations which have previously 
been reported in alcoholic patients. Most studies have 
utilized a single concentration of PHA or pokeweed 
Table 2. Age-related Comparisons of Proliferative Response and Proliferation Coefficient in Controls 
Controls, Controls, 
Total control group 20-40 years 41 -60 years 
Con A (pglml) (51)’ (38) P (1 3) P 
0 533 f 55t 498 f 54 NSS 636 f 142 NS 
1 2200 f 450 2077 f 396 NS 2560 f 1326 NS 
5 6144 f 869 6174 f 981 NS 6057 f 1843 NS 
10 10231 f 1030 10467 f 1139 NS 9540 f 2276 NS 
20 13711 f 1327 14703 f 1513 NS 10811 f 2586 NS 
40 15757 f 1394 16721 f 1609 NS 12942 f 2640 NS 
KP§ 12.58 & 2.68 11.46f 1.86 NS 15.86 f 8.93 NS 
* Numbers in parentheses, number of subjects tested. 
t Mean cpm f. SEM/~@ PBM. * NS, not significant compared to total control group and alternate age-control group. 
5 K,, coefficient of natural logarithmic difference in proliferation for each Con A condition. 
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Table 3. Con A Induced Proliferative Response in Alcoholic Patients 
Con A (rg/ml) controls (51)' AHt (1 4) PS P AWLD (9) P CAC (1 1) 
0 533 f 555 1287 f 378 586 f 85 665 f 101 
1681 f 224 1 2200 f 450 2820 f 556 1557 f 314 
5 6144 f 869 5982 f 1086 321 2 f 469 (0.01 4049 f 343 (0.05 
10 10231 f 1030 7085 * 1018 (0.05 9706 f 4945 6797 f 778 co.01 
20 13711 f 1327 9416 f 1525 (0.05 6932 * 790 (0.01 9051 f 1215 co.01 
40 15757 f 1394 11632 f 2087 1 1299 f 2808 9597 * 635 (0.01 
* Numbers in parentheses, number of subjects tested. 
t AH, alcoholic hepatitis; CAC, compensated alcoholic cimosis; AWLD. alcuholics without liver disease. 
S p values, compared to controls, Student's t test. 
5 Mean cpm f SEM/~ W PBM. 
Table 4. Statistical Significance of the Proliferation Equation among Groups 
Controls AH' CAC AWLD 
0.880 +. 0.050 0.880 * 0.020 0.930 * 0.010 Correlation mefficientt 0.916 f 0.009$ 
KP§ 12.58 f 2.68 3.16 z t  0.71 5.06f 1.15 4.61 f 0.83 
(<O.Ol)T (CO.01) (CO.01) 
Proliferation equation. PR = 6 + Kp In 1x1. 
AH, alcoholic hepatitis; CAC, compensated alcoholic cimhosis; AWLD. alcoholics without liver disease. 
t Correlation ccmffkht (I) of the proliferation equation. 
S Means f SEM. 
8 Kp, coefRdent of natural logarithmic difference in proliferation for each Con A condition. 
7 p value, Student's t test when Kp is compared to control value. 
mitogen4-6. 8.10 while two studies examined the prolifera- 
tive responses to two concentrations each, of PHA and 
Con A.'v9 In all, statistical analyses were accomplished 
using the data obtained at discrete mitogen dosages and 
in none were dose-response proliferation curves obtained. 
In one investigation: the concentrations of PHA and Con 
A used were determined by dose-response curves in 
healthy subjects yielding maximum transformation re- 
sponses. Previous work has shown however, that multiple 
doses of a mitogen are required since abnormalities in 
lymphocyte response may occur only at suboptimal 
The Con A proliferation curve employed in the present 
study demonstrates a variable response to the different 
concentrations of the mitogen (Table 3). Selection of a 
single Con A dose of 40 pg/ml would have resulted in the 
impression that PBM from patients with AH and CAC 
undergo normal proliferative responses. Determination of 
Kp values in lymphocyte transformation assays would 
appear to provide a more reliable approach towards the 
detection of decreased cell-mediated immune function.'* 
The natural logarithmic equation has been used in a 
number of biological conditions where dose-response re- 
lationships are not linear.I2, ''3 l 8  In a similar manner, 
proliferation assays exhibit a decay in the growth rate as 
the concentrations of the mitogen are in~reased . '~ .~~  Al- 
though PBM from alcoholic patients are capable of re- 
sponding to mitogen stimulation, with the In correlation 
in cellular proliferation remaining intact (Table 4), the 
proliferation coefficient is significantly decreased when 
compared to healthy controls. 
The literature is replete with descriptions of multiple 
immunological abnormalities associated with chronic al- 
cohol abuse in the presence or absence of liver disease 
(reviewed in Ref. 2 I), however there is as yet no conclusive 
~ O S ~ S . I ~ V  l6 
evidence to support a pathogenetic role for the host im- 
mune response in ALD. 
This study provides further indication that the transfor- 
mation responses in alcoholic patients may not be related 
to liver disease activity. Although there was no clinical 
indication of malnutrition in the CAC and AWLD pa- 
tients reported in this study, we cannot exclude the pos- 
sibility that subtle changes in nutritional status may have 
influenced the proliferative response to mitogens in the 
patient groups6 
The decreased proliferative response to Con A by alco- 
holic patients reflects a probable perturbation in cell- 
mediated immunity and an immune deficiency state.' 
Application of a natural logarithmic equation to a dose- 
response mitogen driven proliferation assay permits a 
more precise quantitative comparison of immunological 
function between patient groups and healthy volunteers. 
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